July 28, 2023 CS Pharmaceuticals acquires AxeroVision Inc and pipeline for the treatment of Dry Eye Disease due to Meibomian Gland Dysfunction Download Press Release
January 31, 2023 CS Pharmaceuticals Announces Exclusive Licensing of the Chinese Commercialisation Rights to Bersiporocin from Daewoong Download Press Release
October 11, 2022 CS Pharmaceuticals Announces Exclusive Licensing of the Chinese Commercialisation Rights to IBE-814 from Ripple Therapeutics Download Press Release
June 1, 2022 CS Pharmaceuticals announces appointment of John Dawson CBE as Non Executive Director Download Press Release
February 15, 2022 CS Pharmaceuticals Announces Acquisition of Exclusive Chinese Commercialisation Rights to BRONCHITOL® from Pharmaxis Download Press Release
December 12, 2021 CS Pharmaceuticals announces strategic cooperation agreement with Medical Insight to jointly built a digital platform for rare diseases Download Press Release
November 29, 2021 CS Pharmaceuticals announces appointment of Roberto Lee as Non Executive Director Download Press Release
November 22, 2021 CS Pharmaceuticals announces strategic investment by Downing Ventures Download Press Release
September 13, 2021 CS Pharmaceuticals announces opening of Shanghai office to expand Regulatory and Clinical capabilities Download Press Release
June 22, 2021 CS Pharmaceuticals announces appointment of Professor Andrew Wilks as Non Executive Director Download Press Release
June 1, 2021 CS Pharmaceuticals announces appointment of Darren Mercer as Chief Executive Officer Download Press Release
June 1, 2021 CS Pharmaceuticals launches speciality pharmaceuticals business focused on China Download Press Release
